These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37958360)

  • 21. Treatment outcomes of stereotactic ablative body radiotherapy on oligometastases from colorectal cancer: early results of a single institution service evaluation.
    Duong J; Stewart-Lord A; Nariyangadu P; Harrison M; Tsang YM
    BJR Open; 2022; 4(1):20210071. PubMed ID: 36105422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer.
    Mercier C; Claessens M; De Troyer B; Debacker T; Fransis K; Vandeursen H; Ost P; Dirix P
    Front Oncol; 2022; 12():863609. PubMed ID: 35494057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.
    Nicosia L; Franceschini D; Perrone-Congedi F; Casamassima F; Gerardi MA; Rigo M; Mazzola R; Perna M; Scotti V; Fodor A; Iurato A; Pasqualetti F; Gadducci G; Chiesa S; Niespolo RM; Bruni A; Alicino G; Frassinelli L; Borghetti P; Di Marzo A; Ravasio A; De Bari B; Sepulcri M; Aiello D; Mortellaro G; Sangalli C; Franceschini M; Montesi G; Aquilanti FM; Lunardi G; Valdagni R; Fazio I; Scarzello G; Corti L; Vavassori V; Maranzano E; Magrini SM; Arcangeli S; Gambacorta MA; Valentini V; Paiar F; Ramella S; Di Muzio NG; Livi L; Jereczek-Fossa BA; Osti MF; Scorsetti M; Alongi F
    Radiother Oncol; 2022 Jan; 166():92-99. PubMed ID: 34748855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
    Palma DA; Olson R; Harrow S; Gaede S; Louie AV; Haasbeek C; Mulroy L; Lock M; Rodrigues GB; Yaremko BP; Schellenberg D; Ahmad B; Griffioen G; Senthi S; Swaminath A; Kopek N; Liu M; Moore K; Currie S; Bauman GS; Warner A; Senan S
    Lancet; 2019 May; 393(10185):2051-2058. PubMed ID: 30982687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases.
    Lee YH; Kang KM; Choi HS; Ha IB; Jeong H; Song JH; Jang IS; Kim SH; Lee JW; Rhee DY; Jeong BK
    Thorac Cancer; 2018 Dec; 9(12):1671-1679. PubMed ID: 30298701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy.
    Meacci E; Nachira D; Congedo MT; Ibrahim M; Pariscenti G; Petrella F; Casiraghi M; De Stefani A; Del Regno L; Peris K; Triumbari EKA; Schinzari G; Rossi E; Petracca-Ciavarella L; Vita ML; Chiappetta M; Siciliani A; Peritore V; Manitto M; Morelli L; Zanfrini E; Tabacco D; Calabrese G; Bardoni C; Evangelista J; Spaggiari L; Margaritora S
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
    Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY
    JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.
    Hattori N; Kanemitsu Y; Komori K; Shimizu Y; Sano T; Senda Y; Mitsudomi T; Fukui T
    World J Surg; 2013 Jun; 37(6):1315-21. PubMed ID: 23435701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
    Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M
    BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.
    Connor MJ; Smith A; Miah S; Shah TT; Winkler M; Khoo V; Ahmed HU
    Eur Urol Oncol; 2020 Oct; 3(5):582-593. PubMed ID: 32891600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary metastasectomy and repeat metastasectomy for colorectal pulmonary metastases: outcomes from the Dutch Lung Cancer Audit for Surgery.
    van Dorp M; Wolfhagen N; Torensma B; Dickhoff C; Kazemier G; Heineman DJ; Schreurs WH
    BJS Open; 2023 May; 7(3):. PubMed ID: 37146204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
    Franzese C; Marini B; Baldaccini D; Badalamenti M; Navarria P; Bellu L; Franceschini D; Comito T; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Lo Faro L; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4411-4417. PubMed ID: 36109401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
    He K; Hong DS; Tang C; Sezen D; Cox L; Maleki A; Bertolet G; Nguyen QN; Comeaux NI; Schuda L; Chen D; Welsh JW
    Radiother Oncol; 2023 Jun; 183():109618. PubMed ID: 36921766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term Survival of Patients with Lung Metastases from Colorectal and Non-colorectal Cancer Who Underwent Pulmonary Metastasectomy.
    Lumachi F; Mazza F; Del Conte A; Lo Re G; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2015 Jun; 35(6):3563-6. PubMed ID: 26026126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.
    Milosevic M; Edwards J; Tsang D; Dunning J; Shackcloth M; Batchelor T; Coonar A; Hasan J; Davidson B; Marchbank A; Grumett S; Williams NR; Macbeth F; Farewell V; Treasure T
    Colorectal Dis; 2020 Oct; 22(10):1314-1324. PubMed ID: 32388895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
    Franzese C; Vernier V; Franceschini D; Comito T; Navarria P; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Marini B; Galdieri C; Mancosu P; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10495-10503. PubMed ID: 37280407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.
    Blackmon SH; Stephens EH; Correa AM; Hofstetter W; Kim MP; Mehran RJ; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA
    Ann Thorac Surg; 2012 Dec; 94(6):1802-9. PubMed ID: 23063195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.
    Mihai A; Mu Y; Armstrong J; Dunne M; Beriwal S; Rock L; Thirion P; Heron DE; Bird BH; Westrup J; Murphy CG; Huq MS; McDermott R
    J Radiosurg SBRT; 2017; 5(1):43-53. PubMed ID: 29296462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Timmer FEF; Nota IM; Opperman J; van den Bemd B; Geboers B; Ruarus AH; Schouten EAC; de Vries JJJ; Scheffer HJ; van Geel AM; van Waesberghe JHTM; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Haasbeek CJA; Meijerink MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.